Prosecution Insights
Last updated: August 15, 2026

Caregen Co., Ltd.

14 pending office actions • 2 art units • 10 examiners • 0 of 14 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
12
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (64%)
4
Medium (29%)
1
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (14%)
§101 + other3 (21%)
§103 only1 (7%)
§102 only2 (14%)
§112 only1 (7%)
Double-patenting + other1 (7%)
Multi-statute (no §101)4 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
36% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
9
Business / Other
64% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ESPINOSA, CLAUDIA EDILMA 3 51.9% +56.9%
HA, JULIE 2 75.6% +44.2%
KONOPELSKI SNAVEL, SARA ELIZABETH 2 30.0% +38.8%
COFFA, SERGIO 1 61.1% +33.2%
BOWLES, DAVID PAUL 1 69.4% +25.9%
VARADARAJ, ARCHANA 1 100.0% +0.0%
HELLMAN, KRISTINA M 1 65.5% +55.1%
BEANE, RANDALL L 1 32.8% +36.6%
KOMATSU, LI N 1 59.6% +71.0%
NIEBAUER, RONALD T 1 41.1% +33.7%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18009452 COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT KOMATSU, LI N 97d overdue
18038607 PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME BEANE, RANDALL L 4d overdue
17629313 PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF NIEBAUER, RONALD T 3d overdue
18724295 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF HA, JULIE
18724352 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH
18724255 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF COFFA, SERGIO
18695838 PEPTIDE HAVING ACTIVITY FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF VARADARAJ, ARCHANA
18695739 PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF HELLMAN, KRISTINA M

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18009452 COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT KOMATSU, LI N 97d overdue
18038607 PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME BEANE, RANDALL L 4d overdue
17629313 PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF NIEBAUER, RONALD T 3d overdue
18724295 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF HA, JULIE
18724352 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH
18724255 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF COFFA, SERGIO
18697277 PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF ESPINOSA, CLAUDIA EDILMA
18697201 PEPTIDE HAVING ANTI-OBESITY ACTIVITY AND USES THEREOF ESPINOSA, CLAUDIA EDILMA

Top Art Units

Art UnitApps
1658 3
1654 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18724295 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF HA, JULIE §101 Non-Final OA Pending Jun 26, 2024
18724352 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH §101 Non-Final OA Pending Jun 26, 2024
18724255 PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF COFFA, SERGIO 1658 §102§112 Non-Final OA Pending Jun 26, 2024
18697277 PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF ESPINOSA, CLAUDIA EDILMA §102§112DP Non-Final OA Pending Mar 29, 2024
18697201 PEPTIDE HAVING ANTI-OBESITY ACTIVITY AND USES THEREOF ESPINOSA, CLAUDIA EDILMA §112 Non-Final OA Pending Mar 29, 2024
18697386 PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF KONOPELSKI SNAVEL, SARA ELIZABETH §102 Non-Final OA Pending Mar 29, 2024
18695853 PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY, AND USE THEREOF BOWLES, DAVID PAUL §102 Non-Final OA Pending Mar 27, 2024
18695838 PEPTIDE HAVING ACTIVITY FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF VARADARAJ, ARCHANA §102§112 Non-Final OA Pending Mar 27, 2024
18695739 PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF HELLMAN, KRISTINA M §102§112 Non-Final OA Pending Mar 26, 2024
18695537 PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF ESPINOSA, CLAUDIA EDILMA §101§102DP Non-Final OA Pending Mar 26, 2024
18038607 PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME BEANE, RANDALL L 1654 §101§102§112 Non-Final OA 4d overdue Pending May 24, 2023
18009452 COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT KOMATSU, LI N 1658 §102§103§112Other Non-Final OA 97d overdue Pending Dec 09, 2022
18009418 DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF HA, JULIE 1654 §103 Final Rejection Pending Dec 09, 2022
17629313 PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF NIEBAUER, RONALD T 1658 §101§112 Final Rejection 3d overdue Pending Jan 21, 2022

Managing Caregen Co., Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month